{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:10:23Z","timestamp":1759104623903,"version":"3.44.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ijcard.2020.03.070","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T12:21:37Z","timestamp":1591186897000},"page":"109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Moderating effect of obesity on clinical outcomes in NOAC-treated atrial fibrillation patients or just an effect of obesity?"],"prefix":"10.1016","volume":"312","author":[{"given":"Vladimir","family":"Trkulja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2020.03.070_bb0005","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijcard.2019.10.035","article-title":"Patients with higher body mass index treated with direct\/novel oral anticoagulants (DOAC\/NOAC) for atrial fibrillation experience worse clinical outcomes","volume":"301","author":"Lucijanic","year":"2020","journal-title":"Int. J. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcard.2020.03.070_bb0010","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004006","article-title":"Relation of body mass index with adverse outcomes among patients with atrial fibrillation: a meta-analysis and systematic review","volume":"5","author":"Zhu","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2020.03.070_bb0015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1160\/TH11-09-0656","article-title":"A combined pharmacometric analysis of dabigatran etexilate in healthy volunteers and patients with atrial fibrillation or undergoing ortopaedic surgery","volume":"107","author":"Dansirikul","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2020.03.070_bb0020","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/jcph.288","article-title":"Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AF","volume":"54","author":"Girgis","year":"2014","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2020.03.070_bb0025","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/psp4.12347","article-title":"Population pharmacokinetics of apixaban in subjects with nonvalvular atrial fibrillation","volume":"7","author":"Cirincione","year":"2018","journal-title":"CPT Pharmacometrics Syst. Pharmacol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320311475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320311475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:46:48Z","timestamp":1759092408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527320311475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":5,"alternative-id":["S0167527320311475"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.03.070","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Moderating effect of obesity on clinical outcomes in NOAC-treated atrial fibrillation patients or just an effect of obesity?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.03.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}